Previous 10 | Next 10 |
OPKO Health (OPK -0.1%) says that the Omicron COVID-19 variant won't impact the ability of its BioReference Laboratories COVID-19 PCR tests to detect the virus. The company says that BioReference's tests are based on recognizing specific RNA target genes that are common to all coronaviruses, ...
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S. PR Newswire ELMWOOD PARK, N.J. , Nov. 29, 2021 /PRNewswire/ -- BioReference Laboratories, Inc. , an OPKO Health company (NASDAQ: OPK), annou...
MIAMI, Nov. 29, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Piper Sandler 33 rd Annual Virtual Healthcare Conference taking place November 30 through December 2, 2021. A pre-recorded company fireside chat is a...
Are These High Volume Penny Stocks on Your Watchlist? Volume is one of the most important metrics to use when it comes to finding penny stocks to buy. If you’re new to trading or not sure why this is the case, let’s go into detail. For starters, volume is simply the number...
Because the stock market is expected to remain volatile in the near term on concerns over rising inflation, we think it could be wise to add low-priced stocks GlobalStar (GSAT), OPKO Health (OPK), and Energous Corporation (WATT) to one’s watch list now. Wall Street analysts expect thes...
Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q3 2021 Earnings Call Oct 28, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q3 2021 Earnings Call Transcript
OPKO Health Inc. (OPK) Q3 2021 Financial Results Conference Call October 28, 2021 4:30 PM Company Participants Yvonne Briggs – LHA Investor Relations Phillip Frost – Chairman and Chief Executive Officer Steve Rubin – Executive Vice President Jon Cohen – Senior Vice...
OPKO Health (NASDAQ:OPK) posted third-quarter results that beat Wall Street estimates and provided an update on the company's cash position. Quarterly revenue fell nearly 10% to $385.8M, but beat analysts' estimate by $83.53M. Revenue from services in the third quarter of 2021 decreased to $3...
OPKO Health (NASDAQ:OPK): Q3 GAAP EPS of $0.04 beats by $0.05. Revenue of $385.8M (-9.9% Y/Y) beats by $83.53M. Shares -1.63%. Press Release Operating income for the third quarter of 2021 increased 72% to $37.8 million compared with $21.9 million, for the comparable period of 2020. Cash, cash...
MIAMI, Oct. 28, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2021. Business Highlights Health Canada approved NGENLA™ (somatrogon) injection for pediatric grow...
News, Short Squeeze, Breakout and More Instantly...
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common ...
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relat...
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additi...